← SynDRA
INDIRUBIN
SynDRA canonical compound SYN0024848 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
| Primary target(s) | CDK1 | CDK2 | CDK4 | CDK5 | GSK3A | GSK3B |
| Mechanism of action | CDK inhibitor | glycogen synthase kinase inhibitor |
All known targets
- CDK1
- CDK2
- CDK4
- CDK5
- GSK3A
- GSK3B
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
- glycogen synthase kinase inhibitor
Cross-references
Synonyms
- Couroupitine b
- C.I. 75790
- NSC-105327
- Indigo Red
- Couroupitine B
- Indigopurpurin
- (Z)-[2,3'-biindolinylidene]-2',3-dione
- [2,3'-Biindolinylidene]-2',3-dione
- Isoindirubin
- Isoindirubine
- Isoindogotin
- Indirubin [MI]
- 2-(2-hydroxy-1H-indol-3-yl)indol-3-one
- (E)-[2,3'-biindolinylidene]-2',3-dione
- 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-
- C.I. 73200
- Indirubin 3E-form [MI]
- 3-(3-oxo-1H-indol-2-ylidene)-1H-indol-2-one
- 1LXW6D3W2Z
- V86L8P74GI
- 3-(1,3-dihydro-3-oxo-2h-indol-2-ylidene)-1,3-dihydro-2h-indol-2-one
- MFCD00956441
- (Z)-[2,3 inverted exclamation mark -Biindolinylidene]-2 inverted exclamation mark ,3-dione
- (3Z)-3-(1,3-Dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-2H-indol-2-one
- MFCD00221745
- (3E)-3-(1,3-Dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-2H-indol-2-one
- 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, (3E)-
- SMR000466311
- INDARUBICIN
- BRN 0088279
- UNII-V86L8P74GI
- Indirubin,(S)
- Indirubin- Bio-X
- (delta2,3'-Biindoline)-2',3-dione
- CPD000466311
- Indirubin derivative, 1
- BiomolKI_000069
- EM-A05-INDIRUBIN
- [.DELTA.2,3-dione
Look up INDIRUBIN in the interactive SynDRA portal →